- Home
- TECX vs EAF Comparison
TECX vs EAF Comparison
Compare TECX & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- EAF
- Stock Information
- Founded
- TECX 2019
- EAF 1886
- Country
- TECX United States
- EAF United States
- Employees
- TECX N/A
- EAF N/A
- Industry
- TECX
- EAF Industrial Machinery/Components
- Sector
- TECX
- EAF Energy
- Exchange
- TECX Nasdaq
- EAF Nasdaq
- Market Cap
- TECX 387.1M
- EAF 342.1M
- IPO Year
- TECX 2018
- EAF 1995
- Fundamental
- Price
- TECX $18.92
- EAF $14.55
- Analyst Decision
- TECX Buy
- EAF Hold
- Analyst Count
- TECX 6
- EAF 6
- Target Price
- TECX $79.17
- EAF $17.00
- AVG Volume (30 Days)
- TECX 682.4K
- EAF 225.0K
- Earning Date
- TECX 11-06-2025
- EAF 10-24-2025
- Dividend Yield
- TECX N/A
- EAF N/A
- EPS Growth
- TECX N/A
- EAF N/A
- EPS
- TECX N/A
- EAF N/A
- Revenue
- TECX N/A
- EAF $521,894,000.00
- Revenue This Year
- TECX N/A
- EAF N/A
- Revenue Next Year
- TECX N/A
- EAF $11.64
- P/E Ratio
- TECX N/A
- EAF N/A
- Revenue Growth
- TECX N/A
- EAF N/A
- 52 Week Low
- TECX $13.70
- EAF $5.50
- 52 Week High
- TECX $61.07
- EAF $25.30
- Technical
- Relative Strength Index (RSI)
- TECX 55.49
- EAF 52.83
- Support Level
- TECX $18.49
- EAF $12.87
- Resistance Level
- TECX $20.39
- EAF $14.10
- Average True Range (ATR)
- TECX 2.22
- EAF 1.28
- MACD
- TECX 0.14
- EAF -0.19
- Stochastic Oscillator
- TECX 31.09
- EAF 41.36
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.